A Phase II Multicenter Trial to Assess the Safety and Efficacy of Campath-1H and Tacrolimus Followed By Immunosuppression Withdrawal in Liver Transplantation (ITN024ST).

Trial Profile

A Phase II Multicenter Trial to Assess the Safety and Efficacy of Campath-1H and Tacrolimus Followed By Immunosuppression Withdrawal in Liver Transplantation (ITN024ST).

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Dec 2012

At a glance

  • Drugs Alemtuzumab (Primary) ; Tacrolimus (Primary) ; Ciclosporin; Mycophenolate mofetil
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Acronyms TILT
  • Most Recent Events

    • 08 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Nov 2007 Planned number of patients changed to actual number 27 as reported by ClinicalTrials.gov.
    • 16 Oct 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top